A 12-month pilot between Pfizer and San Francisco-based Catalia will use the Mabu Wellness Coach, which can interact with patients using AI algorithms to engage in tailored conversations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback